• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Alopecia areata after dupilumab for atopic dermatitis.

作者信息

Mitchell Krystal, Levitt Jacob

机构信息

University of Oklahoma College of Medicine, Oklahoma City, Oklahoma.

The Mount Sinai Medical Center, Department of Dermatology, New York, New York.

出版信息

JAAD Case Rep. 2018 Jan 16;4(2):143-144. doi: 10.1016/j.jdcr.2017.11.020. eCollection 2018 Mar.

DOI:10.1016/j.jdcr.2017.11.020
PMID:29387767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5790019/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b33a/5790019/934e73413ff1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b33a/5790019/934e73413ff1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b33a/5790019/934e73413ff1/gr1.jpg

相似文献

1
Alopecia areata after dupilumab for atopic dermatitis.度普利尤单抗治疗特应性皮炎后出现斑秃。
JAAD Case Rep. 2018 Jan 16;4(2):143-144. doi: 10.1016/j.jdcr.2017.11.020. eCollection 2018 Mar.
2
Remission of alopecia universalis in a patient with atopic dermatitis treated with dupilumab.使用度普利尤单抗治疗的特应性皮炎患者泛发性斑秃缓解。
JAAD Case Rep. 2019 Jan 12;5(2):116-117. doi: 10.1016/j.jdcr.2018.11.007. eCollection 2019 Feb.
3
Full scalp hair regrowth in a 4-year-old girl with alopecia areata and atopic dermatitis treated with dupilumab.用度普利尤单抗治疗的一名患有斑秃和特应性皮炎的4岁女孩头皮毛发完全再生。
JAAD Case Rep. 2020 Oct 15;6(12):1286-1287. doi: 10.1016/j.jdcr.2020.10.010. eCollection 2020 Dec.
4
[Dupilumab-Associated Healing of Alopecia Areata in an Atopic Dermatitis Patient].[特应性皮炎患者中与度普利尤单抗相关的斑秃愈合情况]
Dtsch Med Wochenschr. 2019 May;144(9):602-605. doi: 10.1055/a-0836-3119. Epub 2019 Apr 26.
5
[Hair growth with dupilumab in alopecia areata universalis and atopic dermatitis].[度普利尤单抗治疗泛发性斑秃和特应性皮炎时的毛发生长]
Dermatologie (Heidelb). 2022 Jul;73(7):556-559. doi: 10.1007/s00105-021-04898-y. Epub 2021 Oct 5.
6
Long-Term Efficacy of Dupilumab in Alopecia Areata.斑秃患者使用度普利尤单抗的长期疗效。
Am J Case Rep. 2022 Jun 21;23:e936488. doi: 10.12659/AJCR.936488.
7
Remission of Alopecia Universalis after 1 Year of Treatment with Dupilumab in a Patient with Severe Atopic Dermatitis.度普利尤单抗治疗1年后，重度特应性皮炎患者泛发性斑秃缓解
Skin Appendage Disord. 2022 Jan;8(1):38-41. doi: 10.1159/000517832. Epub 2021 Jul 27.
8
Improvement of alopecia areata with Dupilumab in a patient with severe atopic dermatitis and review the literature.达必妥治疗中重度特应性皮炎伴斑秃患者 1 例并文献复习
Australas J Dermatol. 2020 May;61(2):e223-e225. doi: 10.1111/ajd.13208. Epub 2019 Nov 25.
9
Improvement of atopic dermatitis and alopecia universalis with dupilumab.度普利尤单抗治疗特应性皮炎和泛发性斑秃的疗效观察
Dermatol Reports. 2021 Dec 28;14(2):9359. doi: 10.4081/dr.2022.9359. eCollection 2022 Jun 16.
10
Dupilumab for the treatment of alopecia areata in pediatric patients with atopic dermatitis: A scoping review.治疗特应性皮炎儿童斑秃患者的度普利尤单抗：范围综述。
Pediatr Dermatol. 2024 Nov-Dec;41(6):1123-1126. doi: 10.1111/pde.15691. Epub 2024 Jul 4.

引用本文的文献

1
Alopecia Areata Associated with Dupilumab: National Database Study.度普利尤单抗相关斑秃：全国数据库研究
Diagnostics (Basel). 2025 Jul 21;15(14):1828. doi: 10.3390/diagnostics15141828.
2
Case Report: Omalizumab-associated hair loss: a case of eyebrow alopecia areata, literature review and FAERS database analysis.病例报告：奥马珠单抗相关脱发：1例斑秃性眉毛脱落病例、文献综述及FAERS数据库分析
Front Med (Lausanne). 2025 Jun 27;12:1605826. doi: 10.3389/fmed.2025.1605826. eCollection 2025.
3
Dupilumab and Alopecia Areata: A Possible Combined or Disturbance Therapy? A Review of The Literature.

本文引用的文献

1
IL-4Rα Inhibitor for Atopic Disease.白介素-4 受体α 抑制剂治疗特应性疾病。
Cell. 2017 Jul 13;170(2):222. doi: 10.1016/j.cell.2017.06.046.
2
The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm.斑秃的变化格局：治疗范式
Adv Ther. 2017 Jul;34(7):1594-1609. doi: 10.1007/s12325-017-0542-7. Epub 2017 Jun 23.
3
Dupilumab: First Global Approval.度普利尤单抗：全球首次获批。
度普利尤单抗与斑秃：一种可能的联合治疗或干扰治疗？文献综述
Dermatol Pract Concept. 2024 Oct 30;14(4):e2024270. doi: 10.5826/dpc.1404a270.
4
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective.合并症和特殊人群的中重度特应性皮炎患者的生物制剂和小分子治疗：意大利视角
Dermatol Reports. 2023 Sep 13;16(2):9839. doi: 10.4081/dr.2023.9839. eCollection 2024 Jun 14.
5
Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children.病例报告：度普利尤单抗和巴瑞替尼序贯疗法治疗儿童伴有特应性皮炎的重症斑秃。
Front Immunol. 2024 Jun 6;15:1395288. doi: 10.3389/fimmu.2024.1395288. eCollection 2024.
6
Long-term, observational, real-world study of dupilumab for the treatment of moderate-to-severe atopic dermatitis: a 52-week single-center retrospective analysis in China.长期、观察性、真实世界研究：度普利尤单抗治疗中重度特应性皮炎——中国 52 周单中心回顾性分析。
Arch Dermatol Res. 2024 May 31;316(6):304. doi: 10.1007/s00403-024-03029-6.
7
Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib.病例报告：度普利尤单抗治疗对巴瑞替尼耐药的4岁斑秃患者。
Front Med (Lausanne). 2023 Oct 9;10:1253795. doi: 10.3389/fmed.2023.1253795. eCollection 2023.
8
Delayed Hyperpigmented Injection Site Reactions Due to Chronic Dupilumab Use.长期使用度普利尤单抗导致的延迟性注射部位色素沉着反应
Cureus. 2023 Apr 11;15(4):e37441. doi: 10.7759/cureus.37441. eCollection 2023 Apr.
9
Short communication: Comments on hair disorders associated with dupilumab based on VigiBase.短篇通讯：基于 VigiBase 的有关度普利尤单抗相关毛发疾病的评论。
PLoS One. 2022 Jul 27;17(7):e0270906. doi: 10.1371/journal.pone.0270906. eCollection 2022.
10
Biologic Therapies for the Management of Cutaneous Findings in Genodermatoses: A Review.遗传性皮肤病皮肤表现的生物治疗：综述。
Am J Clin Dermatol. 2022 Sep;23(5):673-688. doi: 10.1007/s40257-022-00700-4. Epub 2022 May 23.
Drugs. 2017 Jul;77(10):1115-1121. doi: 10.1007/s40265-017-0768-3.
4
Cellular and molecular immunologic mechanisms in patients with atopic dermatitis.特应性皮炎患者的细胞和分子免疫机制。
J Allergy Clin Immunol. 2016 Aug;138(2):336-49. doi: 10.1016/j.jaci.2016.06.010.
5
Three months of rifapentine and isoniazid for latent tuberculosis infection.利福喷丁和异烟肼治疗潜伏性结核感染 3 个月。
N Engl J Med. 2011 Dec 8;365(23):2155-66. doi: 10.1056/NEJMoa1104875.